Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

TD-0714: Phase I data

October 31, 2016 7:00 AM UTC

A double-blind, placebo-controlled, U.S. Phase I trial in 50 healthy volunteers showed that once-daily 10, 50, 100 and 200 mg doses of oral TD-0714 for 14 days were generally well tolerated with no se...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article